Fig. 1From: SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trialBox and whisker plot (a) and linear graphic (b) of changes in skin sodium content after 6 weeks treatment with dapagliflozinBack to article page